SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-227281
Filing Date
2009-11-06
Accepted
2009-11-06 14:33:30
Documents
6
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 499092
2 AMENDMENT NUMBER 3 TO RESEARCH COLLABORATION AND LICENSE AGREEMENT dex101.htm EX-10.1 28975
3 CERTIFICATION OF PRESIDENT & CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9403
4 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9373
5 CERTIFICATION OF PRESIDENT & CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 3859
6 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 3793
  Complete submission text file 0001193125-09-227281.txt   555827
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33095 | Film No.: 091164236
SIC: 2834 Pharmaceutical Preparations